Calyxt, inc. exploring strategic alternatives

Roseville, minn. , sept. 22, 2022 /prnewswire/ -- calyxt, inc. (nasdaq: clxt) ("calyxt"), a plant-based synthetic biology company, today announced that its board of directors is evaluating potential strategic alternatives to maximize shareholder value.
CLXT Ratings Summary
CLXT Quant Ranking